Copyright Reports & Markets. All rights reserved.

Global Marine Biopharmaceutical Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Marine Biopharmaceutical Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Drugs
    • 1.2.3 Health Supplement
  • 1.3 Market by Application
    • 1.3.1 Global Marine Biopharmaceutical Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital & Clinic
    • 1.3.3 Pharmacy
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Marine Biopharmaceutical Market Perspective (2016-2027)
  • 2.2 Marine Biopharmaceutical Growth Trends by Regions
    • 2.2.1 Marine Biopharmaceutical Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Marine Biopharmaceutical Historic Market Share by Regions (2016-2021)
    • 2.2.3 Marine Biopharmaceutical Forecasted Market Size by Regions (2022-2027)
  • 2.3 Marine Biopharmaceutical Industry Dynamic
    • 2.3.1 Marine Biopharmaceutical Market Trends
    • 2.3.2 Marine Biopharmaceutical Market Drivers
    • 2.3.3 Marine Biopharmaceutical Market Challenges
    • 2.3.4 Marine Biopharmaceutical Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Marine Biopharmaceutical Players by Revenue
    • 3.1.1 Global Top Marine Biopharmaceutical Players by Revenue (2016-2021)
    • 3.1.2 Global Marine Biopharmaceutical Revenue Market Share by Players (2016-2021)
  • 3.2 Global Marine Biopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Marine Biopharmaceutical Revenue
  • 3.4 Global Marine Biopharmaceutical Market Concentration Ratio
    • 3.4.1 Global Marine Biopharmaceutical Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Marine Biopharmaceutical Revenue in 2020
  • 3.5 Marine Biopharmaceutical Key Players Head office and Area Served
  • 3.6 Key Players Marine Biopharmaceutical Product Solution and Service
  • 3.7 Date of Enter into Marine Biopharmaceutical Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Marine Biopharmaceutical Breakdown Data by Type

  • 4.1 Global Marine Biopharmaceutical Historic Market Size by Type (2016-2021)
  • 4.2 Global Marine Biopharmaceutical Forecasted Market Size by Type (2022-2027)

5 Marine Biopharmaceutical Breakdown Data by Application

  • 5.1 Global Marine Biopharmaceutical Historic Market Size by Application (2016-2021)
  • 5.2 Global Marine Biopharmaceutical Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Marine Biopharmaceutical Market Size (2016-2027)
  • 6.2 North America Marine Biopharmaceutical Market Size by Type
    • 6.2.1 North America Marine Biopharmaceutical Market Size by Type (2016-2021)
    • 6.2.2 North America Marine Biopharmaceutical Market Size by Type (2022-2027)
    • 6.2.3 North America Marine Biopharmaceutical Market Size by Type (2016-2027)
  • 6.3 North America Marine Biopharmaceutical Market Size by Application
    • 6.3.1 North America Marine Biopharmaceutical Market Size by Application (2016-2021)
    • 6.3.2 North America Marine Biopharmaceutical Market Size by Application (2022-2027)
    • 6.3.3 North America Marine Biopharmaceutical Market Size by Application (2016-2027)
  • 6.4 North America Marine Biopharmaceutical Market Size by Country
    • 6.4.1 North America Marine Biopharmaceutical Market Size by Country (2016-2021)
    • 6.4.2 North America Marine Biopharmaceutical Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Marine Biopharmaceutical Market Size (2016-2027)
  • 7.2 Europe Marine Biopharmaceutical Market Size by Type
    • 7.2.1 Europe Marine Biopharmaceutical Market Size by Type (2016-2021)
    • 7.2.2 Europe Marine Biopharmaceutical Market Size by Type (2022-2027)
    • 7.2.3 Europe Marine Biopharmaceutical Market Size by Type (2016-2027)
  • 7.3 Europe Marine Biopharmaceutical Market Size by Application
    • 7.3.1 Europe Marine Biopharmaceutical Market Size by Application (2016-2021)
    • 7.3.2 Europe Marine Biopharmaceutical Market Size by Application (2022-2027)
    • 7.3.3 Europe Marine Biopharmaceutical Market Size by Application (2016-2027)
  • 7.4 Europe Marine Biopharmaceutical Market Size by Country
    • 7.4.1 Europe Marine Biopharmaceutical Market Size by Country (2016-2021)
    • 7.4.2 Europe Marine Biopharmaceutical Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Marine Biopharmaceutical Market Size (2016-2027)
  • 8.2 Asia-Pacific Marine Biopharmaceutical Market Size by Type
    • 8.2.1 Asia-Pacific Marine Biopharmaceutical Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Marine Biopharmaceutical Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Marine Biopharmaceutical Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Marine Biopharmaceutical Market Size by Application
    • 8.3.1 Asia-Pacific Marine Biopharmaceutical Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Marine Biopharmaceutical Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Marine Biopharmaceutical Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Marine Biopharmaceutical Market Size by Region
    • 8.4.1 Asia-Pacific Marine Biopharmaceutical Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Marine Biopharmaceutical Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Marine Biopharmaceutical Market Size (2016-2027)
  • 9.2 Latin America Marine Biopharmaceutical Market Size by Type
    • 9.2.1 Latin America Marine Biopharmaceutical Market Size by Type (2016-2021)
    • 9.2.2 Latin America Marine Biopharmaceutical Market Size by Type (2022-2027)
    • 9.2.3 Latin America Marine Biopharmaceutical Market Size by Type (2016-2027)
  • 9.3 Latin America Marine Biopharmaceutical Market Size by Application
    • 9.3.1 Latin America Marine Biopharmaceutical Market Size by Application (2016-2021)
    • 9.3.2 Latin America Marine Biopharmaceutical Market Size by Application (2022-2027)
    • 9.3.3 Latin America Marine Biopharmaceutical Market Size by Application (2016-2027)
  • 9.4 Latin America Marine Biopharmaceutical Market Size by Country
    • 9.4.1 Latin America Marine Biopharmaceutical Market Size by Country (2016-2021)
    • 9.4.2 Latin America Marine Biopharmaceutical Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Marine Biopharmaceutical Market Size (2016-2027)
  • 10.2 Middle East & Africa Marine Biopharmaceutical Market Size by Type
    • 10.2.1 Middle East & Africa Marine Biopharmaceutical Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Marine Biopharmaceutical Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Marine Biopharmaceutical Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Marine Biopharmaceutical Market Size by Application
    • 10.3.1 Middle East & Africa Marine Biopharmaceutical Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Marine Biopharmaceutical Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Marine Biopharmaceutical Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Marine Biopharmaceutical Market Size by Country
    • 10.4.1 Middle East & Africa Marine Biopharmaceutical Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Marine Biopharmaceutical Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Seattle Genetics
    • 11.1.1 Seattle Genetics Company Details
    • 11.1.2 Seattle Genetics Business Overview
    • 11.1.3 Seattle Genetics Marine Biopharmaceutical Introduction
    • 11.1.4 Seattle Genetics Revenue in Marine Biopharmaceutical Business (2016-2021)
    • 11.1.5 Seattle Genetics Recent Development
  • 11.2 DSM
    • 11.2.1 DSM Company Details
    • 11.2.2 DSM Business Overview
    • 11.2.3 DSM Marine Biopharmaceutical Introduction
    • 11.2.4 DSM Revenue in Marine Biopharmaceutical Business (2016-2021)
    • 11.2.5 DSM Recent Development
  • 11.3 Eisai Co
    • 11.3.1 Eisai Co Company Details
    • 11.3.2 Eisai Co Business Overview
    • 11.3.3 Eisai Co Marine Biopharmaceutical Introduction
    • 11.3.4 Eisai Co Revenue in Marine Biopharmaceutical Business (2016-2021)
    • 11.3.5 Eisai Co Recent Development
  • 11.4 Takeda
    • 11.4.1 Takeda Company Details
    • 11.4.2 Takeda Business Overview
    • 11.4.3 Takeda Marine Biopharmaceutical Introduction
    • 11.4.4 Takeda Revenue in Marine Biopharmaceutical Business (2016-2021)
    • 11.4.5 Takeda Recent Development
  • 11.5 BASF
    • 11.5.1 BASF Company Details
    • 11.5.2 BASF Business Overview
    • 11.5.3 BASF Marine Biopharmaceutical Introduction
    • 11.5.4 BASF Revenue in Marine Biopharmaceutical Business (2016-2021)
    • 11.5.5 BASF Recent Development
  • 11.6 Amway
    • 11.6.1 Amway Company Details
    • 11.6.2 Amway Business Overview
    • 11.6.3 Amway Marine Biopharmaceutical Introduction
    • 11.6.4 Amway Revenue in Marine Biopharmaceutical Business (2016-2021)
    • 11.6.5 Amway Recent Development
  • 11.7 Pfizer
    • 11.7.1 Pfizer Company Details
    • 11.7.2 Pfizer Business Overview
    • 11.7.3 Pfizer Marine Biopharmaceutical Introduction
    • 11.7.4 Pfizer Revenue in Marine Biopharmaceutical Business (2016-2021)
    • 11.7.5 Pfizer Recent Development
  • 11.8 Pelagia (EPAX)
    • 11.8.1 Pelagia (EPAX) Company Details
    • 11.8.2 Pelagia (EPAX) Business Overview
    • 11.8.3 Pelagia (EPAX) Marine Biopharmaceutical Introduction
    • 11.8.4 Pelagia (EPAX) Revenue in Marine Biopharmaceutical Business (2016-2021)
    • 11.8.5 Pelagia (EPAX) Recent Development
  • 11.9 Pharma Mar SA
    • 11.9.1 Pharma Mar SA Company Details
    • 11.9.2 Pharma Mar SA Business Overview
    • 11.9.3 Pharma Mar SA Marine Biopharmaceutical Introduction
    • 11.9.4 Pharma Mar SA Revenue in Marine Biopharmaceutical Business (2016-2021)
    • 11.9.5 Pharma Mar SA Recent Development
  • 11.10 Croda
    • 11.10.1 Croda Company Details
    • 11.10.2 Croda Business Overview
    • 11.10.3 Croda Marine Biopharmaceutical Introduction
    • 11.10.4 Croda Revenue in Marine Biopharmaceutical Business (2016-2021)
    • 11.10.5 Croda Recent Development
  • 11.11 GNC
    • 11.11.1 GNC Company Details
    • 11.11.2 GNC Business Overview
    • 11.11.3 GNC Marine Biopharmaceutical Introduction
    • 11.11.4 GNC Revenue in Marine Biopharmaceutical Business (2016-2021)
    • 11.11.5 GNC Recent Development
  • 11.12 GSK
    • 11.12.1 GSK Company Details
    • 11.12.2 GSK Business Overview
    • 11.12.3 GSK Marine Biopharmaceutical Introduction
    • 11.12.4 GSK Revenue in Marine Biopharmaceutical Business (2016-2021)
    • 11.12.5 GSK Recent Development
  • 11.13 TerSera Therapeutics
    • 11.13.1 TerSera Therapeutics Company Details
    • 11.13.2 TerSera Therapeutics Business Overview
    • 11.13.3 TerSera Therapeutics Marine Biopharmaceutical Introduction
    • 11.13.4 TerSera Therapeutics Revenue in Marine Biopharmaceutical Business (2016-2021)
    • 11.13.5 TerSera Therapeutics Recent Development
  • 11.14 Nordic Naturals
    • 11.14.1 Nordic Naturals Company Details
    • 11.14.2 Nordic Naturals Business Overview
    • 11.14.3 Nordic Naturals Marine Biopharmaceutical Introduction
    • 11.14.4 Nordic Naturals Revenue in Marine Biopharmaceutical Business (2016-2021)
    • 11.14.5 Nordic Naturals Recent Development
  • 11.15 Carlson Labs
    • 11.15.1 Carlson Labs Company Details
    • 11.15.2 Carlson Labs Business Overview
    • 11.15.3 Carlson Labs Marine Biopharmaceutical Introduction
    • 11.15.4 Carlson Labs Revenue in Marine Biopharmaceutical Business (2016-2021)
    • 11.15.5 Carlson Labs Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Marine Biopharmaceutical market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Marine Biopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Drugs
    Health Supplement

    Segment by Application
    Hospital & Clinic
    Pharmacy
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Seattle Genetics
    DSM
    Eisai Co
    Takeda
    BASF
    Amway
    Pfizer
    Pelagia (EPAX)
    Pharma Mar SA
    Takeda
    BASF
    GSK
    TerSera Therapeutics
    Nordic Naturals

    Buy now